Drivers of Orphan Drug Development

被引：6
|
作者：
Mingorance, Ana [1 ]
机构：
[1] Dracaena Consulting SL, Madrid 28036, Spain
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2018年 / 9卷 / 10期
关键词：
Orphan drug; rare disease; pipeline; personalized medicine; RESEARCH-AND-DEVELOPMENT;
D O I：
10.1021/acsmedchemlett.8b00438
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Previously neglected by the pharmaceutical industry, rare diseases and orphan drugs are rapidly becoming mainstream. Both market forces and technology enablers are responsible for this migration and combine to create multiple business approaches. This viewpoint discusses the drivers that attract different companies into this booming orphan drug space.
引用
收藏
页码：962 / 964
页数：5
相关论文
共 50 条
  • [1] Orphan Drug Development
    Pastores, Gregory M.
    Gupta, Punita
    [J]. PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 11 : 64 - 67
  • [2] DRUG DEVELOPMENT - ORPHAN DRUG WINDFALLS
    GERSHON, D
    [J]. NATURE, 1992, 355 (6359) : 381 - 381
  • [3] The Future of Orphan Drug Development
    Woodcock, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) : 146 - 148
  • [4] DRUG DEVELOPMENT FOR ORPHAN DISEASES
    CERAMI, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1978, 65 (03): : 407 - 408
  • [5] Orphan drug clinical development
    Blin, Olivier
    Lefebvre, Marie-Noelle
    Rascol, Olivier
    Micallef, Joelle
    [J]. THERAPIE, 2020, 75 (02): : 141 - 147
  • [6] Accelerating orphan drug development
    Timothy R. Coté
    Kui Xu
    Anne R. Pariser
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 901 - 902
  • [7] Accelerating orphan drug development
    Cote, Timothy R.
    Xu, Kui
    Pariser, Anne R.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (12) : 901 - 902
  • [8] System for the orphan drug development in Japan
    Hirai, T
    [J]. MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 251 - 253
  • [9] The Current Environment in Orphan Drug Development
    Marlene E. Haffner
    [J]. Drug information journal : DIJ / Drug Information Association, 2003, 37 : 373 - 379
  • [10] Orphan Drug Development in Cardiovascular Medicine
    Khan, Muhammad Shahzeb
    Vaduganathan, Muthiah
    Butler, Javed
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (07): : 379 - 381
12345